Is MAR Associated With Hormone‐Related Cancer Risk?
-
By
-
Andrea Surnit
-
August 12, 2026
-
4 min
By
Andrea Surnit
August 12, 2026
In SERENA-6, patients who changed treatment following detection of an ESR1 mutation had a 56% lower risk of disease progression or death.
September 8, 2026
Investigators identify insulin resistance and obesity as possible contributors to neurologic changes.
October 21, 2026
"I just think there's a constitutional crisis that's coming."
September 25, 2026